NVNO Annual FCF
-$18.89 M
-$3.16 M-20.06%
31 December 2023
Summary:
As of January 23, 2025, NVNO annual free cash flow is -$18.89 million, with the most recent change of -$3.16 million (-20.06%) on December 31, 2023. During the last 3 years, it has fallen by -$11.03 million (-140.42%). NVNO annual FCF is now -834.23% below its all-time high of -$2.02 million, reached on December 31, 2015.NVNO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVNO Quarterly FCF
-$4.29 M
-$363.00 K-9.26%
30 September 2024
Summary:
As of January 23, 2025, NVNO quarterly free cash flow is -$4.29 million, with the most recent change of -$363.00 thousand (-9.26%) on September 30, 2024. Over the past year, it has increased by +$692.00 thousand (+13.90%). NVNO quarterly FCF is now -602.92% below its all-time high of -$609.60 thousand, reached on March 31, 2017.NVNO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVNO TTM FCF
-$16.74 M
-$69.00 K-0.41%
30 September 2024
Summary:
As of January 23, 2025, NVNO TTM free cash flow is -$16.74 million, with the most recent change of -$69.00 thousand (-0.41%) on September 30, 2024. Over the past year, it has increased by +$2.15 million (+11.37%). NVNO TTM FCF is now -2646.56% below its all-time high of -$609.60 thousand, reached on March 31, 2017.NVNO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVNO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.1% | +13.9% | +11.4% |
| 3 y3 years | -140.4% | +16.2% | +4.1% |
| 5 y5 years | -196.6% | +16.2% | +4.1% |
NVNO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -35.3% | +16.2% | -42.6% | +11.4% |
| 5 y | 5-year | -201.8% | at low | -270.2% | +16.2% | -190.8% | +11.4% |
| alltime | all time | -834.2% | at low | -602.9% | +16.2% | -2646.6% | +11.4% |
EnVVeno Medical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.29 M(+9.3%) | -$16.74 M(+0.4%) |
| June 2024 | - | -$3.92 M(+10.2%) | -$16.67 M(-3.8%) |
| Mar 2024 | - | -$3.56 M(-28.5%) | -$17.34 M(-8.2%) |
| Dec 2023 | -$18.89 M(+20.1%) | -$4.98 M(+18.1%) | -$18.89 M(+6.3%) |
| Sept 2023 | - | -$4.22 M(-8.0%) | -$17.78 M(-1.6%) |
| June 2023 | - | -$4.58 M(-10.4%) | -$18.06 M(+3.4%) |
| Mar 2023 | - | -$5.11 M(+32.3%) | -$17.46 M(+11.0%) |
| Dec 2022 | -$15.73 M(+28.8%) | -$3.87 M(-14.1%) | -$15.73 M(+4.6%) |
| Sept 2022 | - | -$4.50 M(+12.9%) | -$15.04 M(+16.3%) |
| June 2022 | - | -$3.98 M(+17.5%) | -$12.92 M(+10.1%) |
| Mar 2022 | - | -$3.39 M(+7.0%) | -$11.74 M(-3.9%) |
| Dec 2021 | -$12.22 M(+55.5%) | -$3.17 M(+32.8%) | -$12.22 M(+4.5%) |
| Sept 2021 | - | -$2.38 M(-14.8%) | -$11.69 M(-1.9%) |
| June 2021 | - | -$2.80 M(-27.6%) | -$11.92 M(+12.8%) |
| Mar 2021 | - | -$3.87 M(+46.4%) | -$10.57 M(+34.5%) |
| Dec 2020 | -$7.86 M | -$2.64 M(+0.9%) | -$7.86 M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$2.62 M(+81.4%) | -$6.85 M(+19.0%) |
| June 2020 | - | -$1.44 M(+24.6%) | -$5.76 M(-2.8%) |
| Mar 2020 | - | -$1.16 M(-29.3%) | -$5.92 M(-5.4%) |
| Dec 2019 | -$6.26 M(-1.7%) | -$1.64 M(+7.5%) | -$6.26 M(+3.1%) |
| Sept 2019 | - | -$1.52 M(-5.3%) | -$6.07 M(-3.7%) |
| June 2019 | - | -$1.61 M(+7.4%) | -$6.30 M(+1.1%) |
| Mar 2019 | - | -$1.50 M(+3.2%) | -$6.24 M(-2.0%) |
| Dec 2018 | -$6.37 M(+51.2%) | -$1.45 M(-17.4%) | -$6.37 M(+2.7%) |
| Sept 2018 | - | -$1.75 M(+13.7%) | -$6.20 M(+9.6%) |
| June 2018 | - | -$1.54 M(-5.2%) | -$5.66 M(+8.2%) |
| Mar 2018 | - | -$1.63 M(+27.0%) | -$5.23 M(+24.1%) |
| Dec 2017 | -$4.21 M(+11.1%) | -$1.28 M(+5.8%) | -$4.21 M(+43.6%) |
| Sept 2017 | - | -$1.21 M(+8.5%) | -$2.93 M(+70.1%) |
| June 2017 | - | -$1.11 M(+82.8%) | -$1.72 M(+182.8%) |
| Mar 2017 | - | -$609.60 K | -$609.60 K |
| Dec 2016 | -$3.79 M(+87.5%) | - | - |
| Dec 2015 | -$2.02 M | - | - |
FAQ
- What is enVVeno Medical annual free cash flow?
- What is the all time high annual FCF for enVVeno Medical?
- What is enVVeno Medical annual FCF year-on-year change?
- What is enVVeno Medical quarterly free cash flow?
- What is the all time high quarterly FCF for enVVeno Medical?
- What is enVVeno Medical quarterly FCF year-on-year change?
- What is enVVeno Medical TTM free cash flow?
- What is the all time high TTM FCF for enVVeno Medical?
- What is enVVeno Medical TTM FCF year-on-year change?
What is enVVeno Medical annual free cash flow?
The current annual FCF of NVNO is -$18.89 M
What is the all time high annual FCF for enVVeno Medical?
enVVeno Medical all-time high annual free cash flow is -$2.02 M
What is enVVeno Medical annual FCF year-on-year change?
Over the past year, NVNO annual free cash flow has changed by -$3.16 M (-20.06%)
What is enVVeno Medical quarterly free cash flow?
The current quarterly FCF of NVNO is -$4.29 M
What is the all time high quarterly FCF for enVVeno Medical?
enVVeno Medical all-time high quarterly free cash flow is -$609.60 K
What is enVVeno Medical quarterly FCF year-on-year change?
Over the past year, NVNO quarterly free cash flow has changed by +$692.00 K (+13.90%)
What is enVVeno Medical TTM free cash flow?
The current TTM FCF of NVNO is -$16.74 M
What is the all time high TTM FCF for enVVeno Medical?
enVVeno Medical all-time high TTM free cash flow is -$609.60 K
What is enVVeno Medical TTM FCF year-on-year change?
Over the past year, NVNO TTM free cash flow has changed by +$2.15 M (+11.37%)